Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study / Larson, Ra; Druker, Bj; Guilhot, F; O'Brien, Sg; Riviere, Gj; Krahnke, T; Gathmann, I; Wang, Y; Durant, S; Schwarer, A; Joske, D; Seymour, J; Grigg, A; Ma, D; Arthur, C; Bradstock, K; Joshua, D; Louwagie, A; Martiat, P; Bosly, A; Shistok, C; Lipton, J; Forrest, D; Walker, I; Roy, Dc; Rubinger, M; Bence Bruckler, I; Stewart, D; Kovacs, M; Turner, Ar; Birgens, H; Bjerrum, O; Facon, T; Harousseau, Jl; Tulliez, M; Guerci, A; Maloisel, F; Michallet, M; Andreesen, R; Ner, C; Freund, M; Gautterman, N; Ehninger, G; Deininger, M; Ottman, O; Peschel, C; Fruehauf, S; Neubauer, A; Le Coutre, P; Aulitzky, W; Fanin, R; Rosti, G; Mandelli, F; Lazzarino, M; Morra, E; Carella, A; Petrini, M; Nobile, F; Liso, V; Ferrara, F; Rizzoli, Vittorio; Fiortoni, G; Martinelli, G; Ossenkoppele, G; Browett, P; Gedde Dahl, T; Tangen, Jm; Dahl, I; Odrizoala, J; Hernandez Boulda, Jc; Steegman, Jl; Canizo, C; Diaz, J; Grenena, A; Fernandez, Mn; Stenke, L; Paul, C; Bjoreman, M; Malm, C; Wadenvik, H; Nilsson, Pg; Turesson, I; Hess, U; Solenthaler, M; Clark, Re; Green, Ar; Holyoake, Tl; Lucas, Gs; Smith, G; Milligan, Dw; Rule, Sj; Burnett, Ak; Moroose, R; Wetzler, M; Bearden, J; Cataland, S; Rabinowitz, I; Meisenberg, B; Thompson, K; Graziano, S; Emanuel, P; Gross, H; Cobb, P; Bhatia, R; Dakhil, S; Irwin, D; Issell, B; Pavletic, S; Kuebler, P; Layhe, E; Butra, P; Glass, J; Moore, J; Grant, B; Neill, H; Herzig, R; Burris, H; Petersen, B; Kalaycio, M; Stirewalt, D; Samlowski, W; Berman, E; Limentani, S; Seay, T; Shea, T; Akard, L; Smith, G; Becker, P; Devine, S; Hart, R; Veith, R; Wade, J; Brunvad, M; Kalman, L; Strickland, D; Shurafa, M; Bashey, A; Shadduck, R; Safah, H; Rubenstein, M; Collins, R; Keller, A; Tallman, M; Pecora, A; Agha, M; Homes, H; Guidice, R; Druker, Bj; Guilhot, F; Larson, Ra; O'Brien, Sg; Rowe, J; Schiffer, Ca; Buyse, M; Baccarani, M; Cervantes, F; Cornelissen, J; Fischer, T; Hochaus, A; Hughes, T; Lechner, K; Nielsen, Jl; Reiffers, J; Rousselot, P; Saglio, G; Shepherd, J; Simonsson, B; Gratwohl, A; Goldman, Jm; Talpaz, M; Taylor, K; Verhoef, G.. - In: BLOOD. - ISSN 0006-4971. - (2008).
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study.
Larson RA; Druker BJ; Guilhot F; O'Brien SG; Riviere GJ; Krahnke T; Gathmann I; Wang Y; Durant S; Schwarer A; Joske D; Seymour J; Grigg A; Ma D; Arthur C; Bradstock K; Joshua D; Louwagie A; Martiat P; Bosly A; Shistok C; Lipton J; Forrest D; Walker I; Roy DC; Rubinger M; Bence Bruckler I; Stewart D; Kovacs M; Turner AR; Birgens H; Bjerrum O; Facon T; Harousseau JL; Tulliez M; Guerci A; Maloisel F; Michallet M; Andreesen R; Ner C; Freund M; Gautterman N; Ehninger G; Deininger M; Ottman O; Peschel C; Fruehauf S; Neubauer A; Le Coutre P; Aulitzky W; Fanin R; Rosti G; Mandelli F; Lazzarino M; Morra E; Carella A; Petrini M; Nobile F; Liso V; Ferrara F; RIZZOLI, Vittorio ;Fiortoni G; Martinelli G; Ossenkoppele G; Browett P; Gedde Dahl T; Tangen JM; Dahl I; Odrizoala J; Hernandez Boulda JC; Steegman JL; Canizo C; Diaz J; Grenena A; Fernandez MN; Stenke L; Paul C; Bjoreman M; Malm C; Wadenvik H; Nilsson PG; Turesson I; Hess U; Solenthaler M; Clark RE; Green AR; Holyoake TL; Lucas GS; Smith G; Milligan DW; Rule SJ; Burnett AK; Moroose R; Wetzler M; Bearden J; Cataland S; Rabinowitz I; Meisenberg B; Thompson K; Graziano S; Emanuel P; Gross H; Cobb P; Bhatia R; Dakhil S; Irwin D; Issell B; Pavletic S; Kuebler P; Layhe E; Butra P; Glass J; Moore J; Grant B; Neill H; Herzig R; Burris H; Petersen B; Kalaycio M; Stirewalt D; Samlowski W; Berman E; Limentani S; Seay T; Shea T; Akard L; Smith G; Becker P; Devine S; Hart R; Veith R; Wade J; Brunvad M; Kalman L; Strickland D; Shurafa M; Bashey A; Shadduck R; Safah H; Rubenstein M; Collins R; Keller A; Tallman M; Pecora A; Agha M; Homes H; Guidice R; Druker BJ; Guilhot F; Larson RA; O'Brien SG; Rowe J; Schiffer CA; Buyse M; Baccarani M; Cervantes F; Cornelissen J; Fischer T; Hochaus A; Hughes T; Lechner K; Nielsen JL; Reiffers J; Rousselot P; Saglio G; Shepherd J; Simonsson B; Gratwohl A; Goldman JM; Talpaz M; Taylor K; Verhoef G.
2008-01-01
Citazione
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study / Larson, Ra; Druker, Bj; Guilhot, F; O'Brien, Sg; Riviere, Gj; Krahnke, T; Gathmann, I; Wang, Y; Durant, S; Schwarer, A; Joske, D; Seymour, J; Grigg, A; Ma, D; Arthur, C; Bradstock, K; Joshua, D; Louwagie, A; Martiat, P; Bosly, A; Shistok, C; Lipton, J; Forrest, D; Walker, I; Roy, Dc; Rubinger, M; Bence Bruckler, I; Stewart, D; Kovacs, M; Turner, Ar; Birgens, H; Bjerrum, O; Facon, T; Harousseau, Jl; Tulliez, M; Guerci, A; Maloisel, F; Michallet, M; Andreesen, R; Ner, C; Freund, M; Gautterman, N; Ehninger, G; Deininger, M; Ottman, O; Peschel, C; Fruehauf, S; Neubauer, A; Le Coutre, P; Aulitzky, W; Fanin, R; Rosti, G; Mandelli, F; Lazzarino, M; Morra, E; Carella, A; Petrini, M; Nobile, F; Liso, V; Ferrara, F; Rizzoli, Vittorio; Fiortoni, G; Martinelli, G; Ossenkoppele, G; Browett, P; Gedde Dahl, T; Tangen, Jm; Dahl, I; Odrizoala, J; Hernandez Boulda, Jc; Steegman, Jl; Canizo, C; Diaz, J; Grenena, A; Fernandez, Mn; Stenke, L; Paul, C; Bjoreman, M; Malm, C; Wadenvik, H; Nilsson, Pg; Turesson, I; Hess, U; Solenthaler, M; Clark, Re; Green, Ar; Holyoake, Tl; Lucas, Gs; Smith, G; Milligan, Dw; Rule, Sj; Burnett, Ak; Moroose, R; Wetzler, M; Bearden, J; Cataland, S; Rabinowitz, I; Meisenberg, B; Thompson, K; Graziano, S; Emanuel, P; Gross, H; Cobb, P; Bhatia, R; Dakhil, S; Irwin, D; Issell, B; Pavletic, S; Kuebler, P; Layhe, E; Butra, P; Glass, J; Moore, J; Grant, B; Neill, H; Herzig, R; Burris, H; Petersen, B; Kalaycio, M; Stirewalt, D; Samlowski, W; Berman, E; Limentani, S; Seay, T; Shea, T; Akard, L; Smith, G; Becker, P; Devine, S; Hart, R; Veith, R; Wade, J; Brunvad, M; Kalman, L; Strickland, D; Shurafa, M; Bashey, A; Shadduck, R; Safah, H; Rubenstein, M; Collins, R; Keller, A; Tallman, M; Pecora, A; Agha, M; Homes, H; Guidice, R; Druker, Bj; Guilhot, F; Larson, Ra; O'Brien, Sg; Rowe, J; Schiffer, Ca; Buyse, M; Baccarani, M; Cervantes, F; Cornelissen, J; Fischer, T; Hochaus, A; Hughes, T; Lechner, K; Nielsen, Jl; Reiffers, J; Rousselot, P; Saglio, G; Shepherd, J; Simonsson, B; Gratwohl, A; Goldman, Jm; Talpaz, M; Taylor, K; Verhoef, G.. - In: BLOOD. - ISSN 0006-4971. - (2008).
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Sei sicuro che questo prodotto debba essere cancellato?
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione.
